Skip to main content
. 2007 Nov 14;46(1):220–224. doi: 10.1128/JCM.00660-07

FIG. 4.

FIG. 4.

Activity of daptomycin with or without rifampin at 300 mg every 8 h (q8h) against breakthrough isolate SA0629 and daptomycin-nonsusceptible isolate SA0701 in an in vitro pharmacodynamic model over 96 h in duplicate. D6, daptomycin in 6-mg/kg doses given q24h; R, rifampin at 300-mg doses given q8h; GC, growth control. MICs are in μg/ml.